safety of glp-1 receptor agonists Potential Use and GIP/GLP-1 for Respiratory Disorders: Where Are We at? Frontiers | Exploring the multifaceted

Because every patient is different, every plan is personal

This innovative approach has been validated in both CRC patients and animal models, demonstrating its effectiveness [39, 40]

Asgharpour A, Cazanave SC, Pacana T, Seneshaw M, Vincent R, Banini BA, Kumar DP, Daita K, Min HK, Mirshahi F, Bedossa P, Sun X, Hoshida Y, Koduru SV, Contaifer D Jr, Warncke UO, Wijesinghe DS, Sanyal AJ (2016) A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer

By engaging patients in shared decision-making, clinicians can select the most appropriate starting point and improve long-term outcomes

doi: 10.4103/iju.IJU_15_17 72 BaratiENikzadHKarimianM

That is important to understand